Related Experiment Video
Updated: Jul 16, 2026

09:15
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
Therapeutic vaccine for lymphoma
Seung-Tae Lee1, Sattva S Neelapu, Larry W Kwak
1Department of Lymphoma and Myeloma, The University of Texas, M.D. Anderson Cancer Center, Houston, Texas 77030, USA.
Yonsei Medical Journal
|February 28, 2007
Summary
Tumor-specific idiotype vaccines show promise for treating B-cell malignancies. Ongoing trials and new vaccine types offer hope for effective immunotherapy against lymphoid cancers.
Area of Science:
- Oncology
- Immunology
- Biotechnology
Background:
- B-cell malignancies express unique tumor-specific antigens called idiotypes (Id).
- These idiotypes can be targeted for active immunotherapy.
- Current idiotype-based vaccines have shown promising results in early-stage clinical trials for lymphomas.
Purpose of the Study:
- To explore the potential of idiotype-based immunotherapy for lymphoid malignancies.
- To review the current status and future directions of idiotype vaccine development.
Main Methods:
- Review of phase I/II and III clinical trials for idiotype-targeted vaccines.
- Discussion of emerging vaccine platforms including DNA, dendritic cell, and gene-modified tumor cell therapies.
Main Results:
- Therapeutic vaccines targeting tumor-specific idiotypes have demonstrated promising results in phase I/II studies.
- These vaccines are currently under evaluation in phase III randomized trials.
Conclusions:
- Idiotype-based immunotherapy holds significant potential for treating B-cell malignancies.
- Combination therapies and novel vaccine strategies may lead to effective treatments, potentially reducing reliance on conventional chemotherapy.
Related Concept Videos
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

